Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results Transcript
Welcome to the Alnylam Pharmaceuticals Conference Call to discuss the Positive Topline Results from the APOLLO-B Phase 3 study. (Operator Instructions)
I would now like to hand the conference over to the company. Please go ahead.
Good morning. I'm Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications at Alnylam. With me today are Yvonne Greenstreet, our Chief Executive Officer; Akshay Vaishnaw, our President; Pushkal Garg, our Chief Medical Officer; and Tolga Tanguler, our Chief Commercial Officer.
Also joining us on the line and available for Q&A are Jeff Poulton, our Chief Financial Officer; Rena Denoncourt, Vice President, TTR Franchise Lead; and John Vest, Vice President of Clinical Research.
For those of you participating via conference call, the slides we've made available via webcast can also be accessed by going to the Investors page of our website, alnylam.com/events.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
